Full Text | PDF

Share on facebook Share on tweeters Share on linkedin Share on googleplus

Int J Biol Sci 2020; 16(11):1954-1955. doi:10.7150/ijbs.46891 This issue Cite

Editorial

A potential treatment of COVID-19 with TGF-β blockade

WanJun Chen✉

Mucosal Immunology Section, NIDCR, National Institutes of Health, Bethesda, MD 202892, USA

✉ Corresponding author: WanJun Chen, MD, Chief, Mucosal Immunology Section, NIDCR, National Institutes of Health, Bethesda, MD 202892, wchennih.gov

Citation:
Chen W. A potential treatment of COVID-19 with TGF-β blockade. Int J Biol Sci 2020; 16(11):1954-1955. doi:10.7150/ijbs.46891. https://www.ijbs.com/v16p1954.htm
Other styles

File import instruction

Citation styles

APA
Chen, W. (2020). A potential treatment of COVID-19 with TGF-β blockade. International Journal of Biological Sciences, 16(11), 1954-1955. https://doi.org/10.7150/ijbs.46891.

ACS
Chen, W. A potential treatment of COVID-19 with TGF-β blockade. Int. J. Biol. Sci. 2020, 16 (11), 1954-1955. DOI: 10.7150/ijbs.46891.

NLM
Chen W. A potential treatment of COVID-19 with TGF-β blockade. Int J Biol Sci 2020; 16(11):1954-1955. doi:10.7150/ijbs.46891. https://www.ijbs.com/v16p1954.htm

CSE
Chen W. 2020. A potential treatment of COVID-19 with TGF-β blockade. Int J Biol Sci. 16(11):1954-1955.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image

©2024 Ivyspring International Publisher. Terms of use